by
Sean Ruck, Contributing Editor | June 18, 2019
From the June 2019 issue of HealthCare Business News magazine
HCB News: How do you predict nuclear medicine will change in the next five to 10 years?
VP: We will continue to witness massive growth in new radiopharmaceuticals and technologies. I predict that the therapeutic component of the nuclear medicine practice will grow to where radiation oncology and immunotherapy is today, and therefore, we will need highly skilled subspecialists to perform these procedures in the future.
HCB News: Is there anything else you’d like to cover?
VD: I am grateful for the opportunity, and I look forward to working with an incredibly talented team of SNMMI leaders and staff in order to turn these strategic priorities and goals into reality.
Back to HCB News